dr. thomas hutson on conventional and novel combination therapies for first-line advanced rcc
Published 1 year ago • 79 plays • Length 6:38Download video MP4
Download video MP3
Similar videos
-
6:44
dr. thomas hutson on long-term durable response after 4 years follow-up in the clear study
-
27:41
advanced renal cell carcinoma treatment considerations, featuring dr. thomas hutson
-
8:40
next-generation therapies in rcc: examining tivozanib and belzutifan
-
6:07
goals of therapy in advanced rcc
-
0:41
tivozanib for advanced rcc #kidneycancer #cancerawareness #cancer #cancertreatment #cancerscreening
-
2:49
hutson: emerging targeted therapies in rcc
-
1:03
dr. hutson discusses the phase iii atlas study in rcc
-
5:07
is collagen making your health worse? the surprising oxalate connection
-
10:50
resectable pancreatic cancer debate: total neoadjuvant vs adjuvant therapy - adjuvant therapy
-
16:49
theranostics in prostate cancer
-
6:18
novel combinations in kidney cancer
-
1:36
dr. thomas hutson on drug sequencing in renal cell carcinoma
-
29:12
lenvima® (lenvatinib) everolimus, featuring dr. thomas hutson
-
1:14
dr. hutson gives an analysis of the phase iii atlas trial in rcc
-
8:34
promising treatments in advanced rcc
-
0:55
dr. hutson on tivozanib for renal cell carcinoma
-
5:16
rcc first-line toxicity considerations
-
8:40
advanced rcc sequencing challenges
-
8:10
choosing among tkis in advanced rcc
-
7:54
combination therapies in renal cell carcinoma
-
1:27
dr. fishman discusses available agents to treat patients with rcc
-
1:34
dr. quinn on combinations of targeted therapy in rcc